A double-blind, randomised, placebo-controlled, phase 2b study evaluating sorafenib in combination with paclitaxel as a first-line therapy in patients with HER2-negative advanced breast cancer

William J. Gradishar, Virginia Kaklamani, Tarini Prasad Sahoo, D. Lokanatha, Vinod Raina, Shailesh Bondarde, Minish Jain, Sunhee Ro, Nathalie A. Lokker, Lee S. Schwartzberg

European Journal of Cancer · 2012 · 84 citations · 28 references

Concepts

References

28